How Much GHRP-2 Acetate Per Day? (Dosing Guide)

A 2019 study published in the Journal of Clinical Endocrinology & Metabolism found that GHRP-2 administered at 1 mcg/kg body weight produced peak serum growth hormone levels 8–12 times baseline within 30 minutes. But only when administered at least four hours after the previous dose. Dose it too soon, and receptor desensitisation cuts that response by more than half. Most dosing protocols ignore this timing constraint entirely, which is why so many researchers report 'non-response' with peptides that should work.

Our team has worked with research protocols involving GHRP-2 for years. The gap between effective dosing and wasted product comes down to three factors most suppliers never explain: receptor saturation dynamics, pulsatile secretion windows, and gastric clearance timing.

How much GHRP-2 acetate should be administered per day?

GHRP-2 acetate is typically administered at 100–300 mcg per dose, 2–3 times daily, with at least four hours between doses. Total daily intake ranges from 200–900 mcg depending on research objectives. Each dose must be given on an empty stomach (minimum 90 minutes post-meal, 30 minutes pre-meal) to avoid blunted GH response from elevated glucose and insulin.

Most researchers assume 'more is better' and front-load doses without understanding receptor kinetics. GHRP-2 works by binding to ghrelin receptors (GHS-R1a) in the pituitary gland, triggering a pulsatile growth hormone release that mimics natural secretion patterns. The key word is pulsatile. Continuous or overly frequent dosing downregulates receptor sensitivity within 6–8 hours, meaning your third dose of the day at 200 mcg may produce less GH output than your first dose at 100 mcg if spacing was inadequate. This article covers the exact dosing ranges used in clinical research, how timing windows affect receptor availability, what preparation mistakes compromise potency, and why saturation dose doesn't mean optimal dose.

GHRP-2 Acetate Dosing Parameters

Clinical trials have used GHRP-2 doses ranging from 0.1 mcg/kg to 2.0 mcg/kg body weight per administration. For a 70 kg individual, that translates to 7–140 mcg at the low end and up to 300 mcg at saturation dose. The term 'saturation dose'. Typically cited as 1 mcg/kg or roughly 100 mcg for most adults. Refers to the point at which additional peptide does not proportionally increase GH release because available ghrelin receptors are already occupied.

Research conducted at the University of Virginia demonstrated that GHRP-2 at 1 mcg/kg produced maximal GH response in 83% of subjects, while doses above 1.5 mcg/kg showed diminishing returns. GH output increased by less than 15% despite a 50% dose increase. The implication: dosing beyond saturation wastes peptide without meaningful benefit. Standard research protocols use 100–300 mcg per dose depending on whether the goal is receptor binding analysis (lower range) or peak GH output measurement (upper range).

Timing between doses is non-negotiable. GHRP-2 triggers a GH pulse that peaks at 20–30 minutes post-injection and returns to baseline within 90–120 minutes. However, receptor re-sensitisation. The process by which GHS-R1a receptors become available again for ligand binding. Requires 4–6 hours. Dosing more frequently than every four hours results in progressively weaker pulses as receptor density declines. Researchers aiming for three daily pulses typically administer doses at waking (6–7 AM), mid-afternoon (12–1 PM), and pre-bed (9–10 PM), ensuring minimum four-hour spacing.

Gastric State and Insulin Interference

GHRP-2's mechanism depends on low circulating glucose and insulin levels. Elevated insulin. Even modestly, as occurs 60–90 minutes post-meal. Directly inhibits growth hormone-releasing hormone (GHRH) neurons in the hypothalamus, blunting the GH pulse GHRP-2 would otherwise trigger. A 2016 study in Endocrine Reviews found that glucose loads above 75g reduced GHRP-induced GH secretion by 40–60% compared to fasted states.

The gastric clearance rule: administer GHRP-2 at least 90 minutes after eating and at least 30 minutes before the next meal. Protein and fat extend gastric emptying time. A meal containing 30g+ protein or 15g+ fat can elevate insulin for up to two hours, pushing the safe administration window to 120 minutes post-meal. Carbohydrate meals clear faster but spike insulin higher, creating a narrower timing window.

We've found that researchers who dose immediately upon waking (true fasted state, 8–12 hours post-meal) report the most consistent GH response. Mid-day doses require deliberate meal spacing. Skipping lunch or timing the dose 90+ minutes after a light breakfast. Pre-bed doses work well if dinner ends by 7 PM and the dose is administered at 10 PM, ensuring gastric clearance and low insulin before the natural nocturnal GH pulse at 11 PM–1 AM.

Reconstitution and Storage Impact on Effective Dose

Lyophilised GHRP-2 acetate must be reconstituted with bacteriostatic water before administration. The standard concentration is 2 mg peptide per 2 mL bacteriostatic water, yielding 1 mg/mL (1000 mcg/mL). A 100 mcg dose equals 0.1 mL; a 300 mcg dose equals 0.3 mL. Reconstitution introduces two failure points that affect real-world dosing: improper mixing technique and temperature excursions during storage.

GHRP-2 is a hexapeptide (six amino acids: His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) stabilised in acetate salt form. The peptide bond between tryptophan residues is susceptible to oxidative degradation when exposed to air, light, or temperatures above 8°C for extended periods. Once reconstituted, the solution must be refrigerated at 2–8°C and used within 28 days. Beyond that window, degradation reduces potency by an estimated 10–15% per additional week even under refrigeration.

Temperature excursions are the silent dose killer. A vial left at room temperature (20–25°C) for six hours loses approximately 5–8% potency. Leaving it out overnight can reduce effective concentration by 15–20%, meaning your measured 200 mcg dose delivers only 160–170 mcg of active peptide. This is why researchers using high-purity research peptides emphasise cold chain integrity from synthesis to administration. Potency loss is irreversible and undetectable without HPLC testing.

GHRP-2 Acetate Per Day: Dosing Comparison

What If: GHRP-2 Dosing Scenarios

What If I Accidentally Dose GHRP-2 Less Than Four Hours After the Previous Injection?

Skip the dose and resume your regular schedule at the next planned administration time. Dosing within four hours creates receptor competition. The second dose binds to fewer available GHS-R1a sites, producing a blunted GH pulse that wastes peptide without therapeutic benefit. Research from the Mayo Clinic Endocrinology Lab showed that GHRP-2 administered at three-hour intervals produced 30–40% lower GH output on the second pulse compared to baseline, and the third pulse (at six hours total) was nearly negligible. Receptor density doesn't recover instantaneously when ligand is cleared. The re-sensitisation process involves receptor recycling and membrane re-insertion, which takes 240+ minutes.

What If I Dose GHRP-2 Immediately After a High-Carbohydrate Meal?

Expect minimal to no GH response. Elevated blood glucose triggers insulin secretion, which directly suppresses hypothalamic GHRH neurons. The upstream signal GHRP-2 amplifies. A 2018 study in Metabolism: Clinical and Experimental found that GHRP-2 administered 30 minutes post-glucose load (75g oral glucose tolerance test) produced GH levels only 1.5–2× baseline versus the typical 8–12× seen in fasted states. The peptide binds to receptors normally, but the downstream cascade is inhibited at the hypothalamic level. Wait a minimum 90 minutes after carbohydrate intake, or 120 minutes after mixed meals containing protein and fat, before dosing.

What If My Reconstituted GHRP-2 Was Left at Room Temperature Overnight?

Discard the vial and prepare a fresh solution. Peptide bonds in GHRP-2 begin denaturing at temperatures above 8°C, and an eight-hour room temperature exposure can reduce potency by 15–25%. A loss you cannot detect visually or recover through refrigeration. Degraded peptide still dissolves, still measures the correct volume, and still appears clear. But the amino acid sequence may be partially cleaved or oxidised, rendering it biologically inactive. Our experience working with peptide stability shows that even short temperature excursions compound over time: a vial exposed to 22°C for six hours, then refrigerated, then exposed again 48 hours later, degrades faster than a vial maintained at constant 4°C.

The Unvarnished Truth About GHRP-2 Dosing

Here's the honest answer: most GHRP-2 'non-responders' aren't actually non-responders. They're mis-dosers. The peptide works through a well-characterised receptor pathway (GHS-R1a → GHRH neurons → somatotrophs → GH secretion) that's been replicated in hundreds of studies since the 1990s. When someone reports 'no effect' from GHRP-2, the failure is almost always one of three things: dosing too soon after eating (insulin block), dosing too frequently (receptor saturation), or using degraded product (storage failure).

The mechanism is unforgiving. Ghrelin receptors don't care about your schedule or convenience. They respond to ligand availability, competitive inhibition from elevated insulin, and their own recycling kinetics. Dose GHRP-2 at 200 mcg three hours after your last dose, and you'll get maybe 30% of the GH output you'd see with proper six-hour spacing. Dose it 45 minutes after lunch, and you'll get close to zero output regardless of how pure the peptide is. The protocol matters as much as the product.

Another hard truth: saturation dose is not optimal dose for every research objective. If you're studying receptor binding kinetics, 100 mcg may be ideal because it isolates the ligand-receptor interaction without overwhelming the system. If you're measuring peak GH secretion capacity, 300 mcg pushes closer to physiological ceiling. But if you're running a multi-week protocol and want consistent, repeatable pulses without receptor downregulation, 150–200 mcg dosed twice daily with proper spacing outperforms higher doses crammed into short windows. More peptide doesn't always mean more effect. It often means more waste and faster tolerance.

GHRP-2 acetate remains one of the most reliable tools in growth hormone research precisely because its pharmacokinetics are predictable. Dose it correctly. Fasted state, proper spacing, stable storage. And the GH response is consistent across subjects and sessions. Dose it carelessly, and you'll blame the peptide for a protocol failure. The difference between the two isn't the compound. It's the attention to detail in reconstitution, timing, and gastric state. That's the part most guides skip, and it's the part that determines whether your research generates usable data or expensive noise.

GHRP-2 acetate dosing isn't complex, but it is precise. The peptide's half-life is approximately 20 minutes in circulation, meaning it clears quickly and doesn't accumulate. Which is why pulsatile dosing works and continuous infusion doesn't. The four-hour spacing rule exists because receptor biology dictates it, not because it's a convenient number. The fasted-state requirement exists because insulin physiology overrides ghrelin signalling at the hypothalamic level, not because someone decided to make protocols harder. When you understand the mechanisms, the rules stop feeling arbitrary and start feeling necessary. That's the shift from following a dosing chart to running a legitimate research protocol. And it's the only way GHRP-2 delivers the data it's capable of producing.